The Anti-Ma (IgG + IgA) biomarker is a diagnostic marker used to detect autoantibodies against Ma antigens, which are proteins found in the brain, particularly in the Purkinje cells of the cerebellum. These antibodies are typically associated with autoimmune responses that target the central nervous system (CNS). The Anti-Ma test, often part of a broader neurological autoantibody panel like Vibrant America’s Neural Zoomer Plus, is crucial for identifying potential paraneoplastic syndromes and other neurological autoimmune disorders.
What It Measures
The Anti-Ma (IgG + IgA) test detects IgG and IgA antibodies directed against Ma antigens, which are involved in neuronal function. These antibodies can target intracellular or membrane-associated proteins in neurons, particularly those related to the cerebellum and brainstem, and are considered a hallmark of certain paraneoplastic neurological disorders.
Clinical Relevance
Anti-Ma antibodies are strongly associated with paraneoplastic cerebellar degeneration (PCD) and other autoimmune neurological conditions. These conditions occur when the immune system mistakenly attacks the nervous system, often in response to an underlying malignancy. Anti-Ma (IgG + IgA) testing is particularly relevant for diagnosing the following:
-
Paraneoplastic Cerebellar Degeneration (PCD):
-
This condition is often associated with cancers, particularly ovarian, breast, and small-cell lung cancer. Anti-Ma antibodies are found in a significant percentage of patients with PCD and are commonly linked to cerebellar ataxia, which affects motor coordination and balance.
-
Patients may present with subacute cerebellar ataxia, dysarthria (speech difficulty), and nystagmus (involuntary eye movements).
-
-
Paraneoplastic Syndromes:
-
These are a group of disorders that occur when the immune system targets healthy tissue, often triggered by the presence of cancer. Anti-Ma antibodies can be present in paraneoplastic neurological syndromes, especially those affecting the cerebellum and brainstem.
-
-
Neurodegenerative Diseases:
-
Some research suggests that Anti-Ma antibodies may also be present in neurodegenerative diseases, though these cases are less common. The role of Anti-Ma in such conditions is still under investigation.
-
Interpretation of Results
-
Positive Result (IgG/IgA):
-
A positive test for Anti-Ma antibodies suggests an autoimmune attack on the nervous system, particularly in the cerebellum. This is commonly seen in paraneoplastic cerebellar degeneration or other autoimmune conditions affecting the CNS.
-
Further testing, including cancer screening (e.g., CT scans, PET scans), is recommended to rule out an underlying malignancy. If a malignancy is found, treating the cancer often leads to stabilization or improvement of neurological symptoms.
-
-
Negative Result:
-
A negative result typically indicates that Anti-Ma antibodies are not present, which reduces the likelihood of paraneoplastic cerebellar degeneration but does not exclude other autoimmune or neurodegenerative conditions.
-
However, the absence of Anti-Ma antibodies does not rule out the presence of paraneoplastic syndromes, as other autoantibodies may be involved in different presentations of these disorders.
-
Testing Considerations
-
Panel Context: The Anti-Ma (IgG + IgA) test is typically part of a broader neuroautoantibody panel designed to evaluate various antibodies that may contribute to neurological symptoms such as balance issues, muscle weakness, and cognitive dysfunction. It is often used in conjunction with other biomarkers like Anti-Yo, Anti-Hu, and Anti-Ri, which are also associated with paraneoplastic syndromes.
-
Complementary Tests:
-
Cancer Screening: A positive result for Anti-Ma antibodies may prompt further testing to identify any underlying cancer, especially ovarian, breast, or lung cancer, which are most commonly associated with paraneoplastic cerebellar degeneration.
-
CSF Analysis: For patients with neurological symptoms, cerebrospinal fluid (CSF) analysis can provide additional insight into the presence of autoimmune activity in the CNS.
-
-
Limitations:
-
The presence of Anti-Ma antibodies is not always indicative of paraneoplastic cerebellar degeneration or malignancy. In some cases, these antibodies may be present in non-cancerous autoimmune conditions or neurodegenerative diseases.
-
False positives can also occur in patients with other autoimmune conditions, so clinical correlation with symptoms is essential for accurate diagnosis.
-
Treatment Implications
-
Immunotherapy: For autoimmune conditions, particularly paraneoplastic cerebellar degeneration, immunosuppressive therapies such as IVIg, steroids, or plasmapheresis may be used to reduce the immune response and alleviate symptoms.
-
Cancer Treatment: If a malignancy is identified, tumor resection or other cancer treatments may help improve neurological symptoms associated with paraneoplastic syndromes.
Conclusion
Anti-Ma (IgG + IgA) testing is an important tool for diagnosing autoimmune neurological disorders, particularly paraneoplastic cerebellar degeneration. A positive result suggests an autoimmune response against the cerebellum, often triggered by an underlying malignancy. Early detection and treatment are crucial for managing both the neurological symptoms and any associated cancer, making this test a key part of comprehensive neurological care.
All Your Lab Results.
One Simple Dashboard.
Import, Track, and Share Your Lab Results Easily
Import, Track, and Share Your Lab Results
Import lab results from multiple providers, track changes over time, customize your reference ranges, and get clear explanations for each result. Everything is stored securely, exportable in one organized file, and shareable with your doctor—or anyone you choose.
Cancel or upgrade anytime
Laboratories
Bring All Your Lab Results Together — In One Place
We accept reports from any lab, so you can easily collect and organize all your health information in one secure spot.
Pricing Table
Gather Your Lab History — and Finally Make Sense of It
Finally, Your Lab Results Organized and Clear
Personal plans
$79/ year
Advanced Plan
Access your lab reports, explanations, and tracking tools.
- Import lab results from any provider
- Track all results with visual tools
- Customize your reference ranges
- Export your full lab history anytime
- Share results securely with anyone
- Receive 5 reports entered for you
- Cancel or upgrade anytime
$250/ once
Unlimited Account
Pay once, access everything—no monthly fees, no limits.
- Import lab results from any provider
- Track all results with visual tools
- Customize your reference ranges
- Export your full lab history anytime
- Share results securely with anyone
- Receive 10 reports entered for you
- No subscriptions. No extra fees.
$45/ month
Pro Monthly
Designed for professionals managing their clients' lab reports
- Import lab results from any provider
- Track lab results for multiple clients
- Customize reference ranges per client
- Export lab histories and reports
- Begin with first report entered by us
- Cancel or upgrade anytime
About membership
What's included in a Healthmatters membership
Import Lab Results from Any Source
See Your Health Timeline
Understand What Your Results Mean
Visualize Your Results
Data Entry Service for Your Reports
Securely Share With Anyone You Trust
Let Your Lab Results Tell the Full Story
Once your results are in one place, see the bigger picture — track trends over time, compare data side by side, export your full history, and share securely with anyone you trust.
Bring all your results together to compare, track progress, export your history, and share securely.
What Healthmatters Members Are Saying
Frequently asked questions
Healthmatters is a personal health dashboard that helps you organize and understand your lab results. It collects and displays your medical test data from any lab in one secure, easy-to-use platform.
- Individuals who want to track and understand their health over time.
- Health professionals, such as doctors, nutritionists, and wellness coaches, need to manage and interpret lab data for their clients.
With a Healthmatters account, you can:
- Upload lab reports from any lab
- View your data in interactive graphs, tables, and timelines
- Track trends and monitor changes over time
- Customize your reference ranges
- Export and share your full lab history
- Access your results anytime, from any device
Professionals can also analyze client data more efficiently and save time managing lab reports.
Healthmatters.io personal account provides in-depth research on 10000+ biomarkers, including information and suggestions for test panels such as, but not limited to:
- The GI Effects® Comprehensive Stool Profile,
- GI-MAP,
- The NutrEval FMV®,
- The ION Profile,
- Amino Acids Profile,
- Dried Urine Test for Comprehensive Hormones (DUTCH),
- Organic Acids Test,
- Organix Comprehensive Profile,
- Toxic Metals,
- Complete Blood Count (CBC),
- Metabolic panel,
- Thyroid panel,
- Lipid Panel,
- Urinalysis,
- And many, many more.
You can combine all test reports inside your Healthmatters account and keep them in one place. It gives you an excellent overview of all your health data. Once you retest, you can add new results and compare them.
If you are still determining whether Healthmatters support your lab results, the rule is that if you can test it, you can upload it to Healthmatters.
We implement proven measures to keep your data safe.
At HealthMatters, we're committed to maintaining the security and confidentiality of your personal information. We've put industry-leading security standards in place to help protect against the loss, misuse, or alteration of the information under our control. We use procedural, physical, and electronic security methods designed to prevent unauthorized people from getting access to this information. Our internal code of conduct adds additional privacy protection. All data is backed up multiple times a day and encrypted using SSL certificates. See our Privacy Policy for more details.